Evidence map›Paper›PMID 22209231›Full record

ArticleVirology2012

The lectins griffithsin, cyanovirin-N and scytovirin inhibit HIV-1 binding to the DC-SIGN receptor and transfer to CD4(+) cells.

Kabamba B Alexandre, Elin S Gray, Hazel Mufhandu, James B McMahon, Ereck Chakauya, Barry R O'Keefe, Rachel Chikwamba, Lynn Morris

Abstract read
In one paragraph

Article in Virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 52 citations in OpenAlex.

  1. Review
  2. Lectins and lectibodies: potential promising antiviral agents.Cellular & molecular biology letters · 2022
    Review
  3. Plant lectins as prospective antiviral biomolecules in the search for COVID-19 eradication strategies.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2022
    Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kabamba B AlexandreNational Institute for Communicable Diseases, Johannesburg, South Africa.
Elin S Gray
Hazel Mufhandu
James B McMahon
Ereck Chakauya
Barry R O'Keefe
Rachel Chikwamba
Lynn Morris
Council for Scientific and Industrial Research · ZANational Institute for Communicable DiseasesTarget (United States) · US

Funding

Molecular Targets ProgramZICBC010469 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI OKEEFE, BARRY · 2009 to 2018
$31.4M
TUBERCULOSIS SUPPLEMENTD43TW000231 · FIC · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI ABDOOL KARIM, QUARRAISHA · 1993 to 2014
$13.1M
FIC NIH HHS D43 TW000231FIC NIH HHS D43TW00231Intramural NIH HHS
6 · The paper itself

Abstract

It is generally believed that during the sexual transmission of HIV-1, the glycan-specific DC-SIGN receptor binds the virus and mediates its transfer to CD4(+) cells. The lectins griffithsin (GRFT), cyanovirin-N (CV-N) and scytovirin (SVN) inhibit HIV-1 infection by binding to mannose-rich glycans on gp120. We measured the ability of these lectins to inhibit both the HIV-1 binding to DC-SIGN and the DC-SIGN-mediated HIV-1 infection of CD4(+) cells. While GRFT, CV-N and SVN were moderately inhibitory to DC-SIGN binding, they potently inhibited DC-SIGN-transfer of HIV-1. The introduction of the 234 glycosylation site abolished HIV-1 sensitivity to lectin inhibition of binding to DC-SIGN and virus transfer to susceptible cells. However, the addition of the 295 glycosylation site increased the inhibition of transfer. Our data suggest that GRFT, CV-N and SVN can block two important stages of the sexual transmission of HIV-1, DC-SIGN binding and transfer, supporting their further development as microbicides.

Indexed as

Algal ProteinsBacterial ProteinsCarrier ProteinsCD4-Positive T-LymphocytesCell Adhesion MoleculesCell LineDC-Specific ICAM-3 Grabbing NonintegrinDown-RegulationHIV-1HIV Envelope Protein gp120HIV InfectionsHumansLectinsLectins, C-TypeMembrane ProteinsPlant LectinsAlgal ProteinsBacterial ProteinsCarrier ProteinsCell Adhesion Moleculescyanovirin NDC-Specific ICAM-3 Grabbing Nonintegringriffithsin protein, GriffithsiaHIV Envelope Protein gp120LectinsLectins, C-TypeMembrane ProteinsPlant LectinsReceptors, Cell SurfaceReceptors, HIVscytovirin protein, S varium

Identifiers

PMID22209231
PMCPMC3274779
OpenAlexW2071146614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.